Spectrum To Pay $206M For Cancer Drug Manufacturer
Nevada drug company Spectrum Pharmaceuticals Inc. has acquired Colorado-based drugmaker Allos Therapeutics Inc., which manufactures a leading cancer treatment drug, for roughly $206 million, Spectrum said Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article